Cargando…

Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany – a mathematical modelling study

BACKGROUND: Epidemiological studies suggest that reduced exposure to varicella might lead to an increased risk for herpes zoster (HZ). Reduction of exposure to varicella is a consequence of varicella vaccination but also of demographic changes. We analyzed how the combination of vaccination programs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horn, Johannes, Damm, Oliver, Greiner, Wolfgang, Hengel, Hartmut, Kretzschmar, Mirjam E., Siedler, Anette, Ultsch, Bernhard, Weidemann, Felix, Wichmann, Ole, Karch, André, Mikolajczyk, Rafael T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761134/ https://www.ncbi.nlm.nih.gov/pubmed/29316913 http://dx.doi.org/10.1186/s12916-017-0983-5

Ejemplares similares

Systematic review of models assessing the economic value of routine varicella and herpes zoster vaccination in high-income countries
por: Damm, Oliver, et al.
Publicado: (2015)

Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany
por: Ultsch, Bernhard, et al.
Publicado: (2013)

Herpes zoster in Germany: Quantifying the burden of disease
por: Ultsch, Bernhard, et al.
Publicado: (2011)

Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany
por: Wiese-Posselt, Miriam, et al.
Publicado: (2017)

Cost-effectiveness of human papillomavirus vaccination in Germany
por: Damm, Oliver, et al.
Publicado: (2017)

Herpes Zoster and Varicella
por: Fordyce, A. Dingwall
Publicado: (1919)

Herpes Zoster and Varicella
por: Chatterjee, Bijoy Krishna
Publicado: (1929)

Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005–2016
por: Zoch-Lesniak, Beate, et al.
Publicado: (2018)

Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015
por: Rieck, Thorsten, et al.
Publicado: (2017)

Trends in age-specific varicella incidences following the introduction of the general recommendation for varicella immunization in Germany, 2006–2022
por: Moek, Felix, et al.
Publicado: (2023)

Epidemiology and cost of seasonal influenza in Germany - a claims data analysis
por: Scholz, Stefan, et al.
Publicado: (2019)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

RELATION OF VARICELLA TO HERPES ZOSTER : I. STATISTICAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Varicella and herpes zoster vaccine development: lessons learned
por: Warren-Gash, Charlotte, et al.
Publicado: (2017)

The positive duration of varicella zoster immunoglobulin M antibody test in herpes zoster
por: Min, Seong-Won, et al.
Publicado: (2016)

Tozinameran: Varicella zoster virus meningitis and herpes zoster infections : case report
Publicado: (2022)

RELATION OF VARICELLA TO HERPES ZOSTER : II. CLINICAL AND EXPERIMENTAL OBSERVATIONS.
por: Rivers, T. M., et al.
Publicado: (1929)

Herpes Zoster in an Immunocompetent Child without a History of Varicella
por: Shang, Bing-Shiau, et al.
Publicado: (2021)

Varicella vaccination coverage of children under two years of age in Germany
por: Reuss, Annicka M, et al.
Publicado: (2010)

An adult co-presented with varicella and herpes zoster caused by varicella zoster virus genotype J, China: a case report
por: Xie, Guangcheng, et al.
Publicado: (2020)

The changing epidemiology of varicella and herpes zoster in Hong Kong before universal varicella vaccination in 2014
por: Chan, D. Y. W., et al.
Publicado: (2018)

Severe Herpes Zoster Following Varicella Vaccination in Immunocompetent Young Children
por: Moodley, Amaran, et al.
Publicado: (2019)

Tozinameran: Herpes varicella-zoster virus infection: 2 case reports
Publicado: (2022)

Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
por: Tayyar, Ralph, et al.
Publicado: (2023)

The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting
por: Sauboin, Christophe, et al.
Publicado: (2019)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

Trends in Hospitalizations With Primary Varicella and Herpes Zoster During the Prevaricella and Initial Postvaricella and Herpes Zoster Vaccine Eras, Connecticut, 1994–2012
por: Humes, Elizabeth A., et al.
Publicado: (2015)

THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTER : SEROLOGIC STUDIES WITH THE VIRUSES AS PROPAGATED IN VITRO
por: Weller, Thomas H., et al.
Publicado: (1958)

THE ETIOLOGIC AGENTS OF VARICELLA AND HERPES ZOSTER : ISOLATION, PROPAGATION, AND CULTURAL CHARACTERISTICS IN VITRO
por: Weller, Thomas H., et al.
Publicado: (1958)

Concurrent Reactivation of Varicella Zoster Virus and Herpes Simplex Virus in an Immunocompetent Child
por: Park, Hyun-Ho, et al.
Publicado: (2004)

A Case of Severe Herpes Zoster and Varicella Occurring Simultaneously in an Aged Patient
por: Overton, R. E.
Publicado: (1926)

Prevalence of a history of prior varicella/herpes zoster infection in multiple sclerosis
por: Manouchehrinia, Ali, et al.
Publicado: (2017)

Herpes zoster duplex bilateralis symmetricus in an immunocompromised patient with recent varicella infection
por: Amonchaisakda, Nuntouchaporn, et al.
Publicado: (2021)

1461. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States
por: Leung, Jessica W, et al.
Publicado: (2022)

Diagnostic Usefulness of Varicella Zoster Virus-Specific Immunoglobulin (Ig) A and IgG in Patients With Herpes Zoster
por: Choi, Sungim, et al.
Publicado: (2022)

Varicella Zoster Virus-Specific Hyperimmunoglobulin in the Adjuvant Treatment of Immunocompromised Herpes Zoster Patients: A Case Series
por: Terheyden, Patrick, et al.
Publicado: (2023)

Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
por: Badur, Selim, et al.
Publicado: (2022)

The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study
por: Melegaro, Alessia, et al.
Publicado: (2018)

Herpes Zoster and Recurrent Herpes Zoster
por: Shiraki, Kimiyasu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c8a0qshascn57tptfditbdlcmi